🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cefixime is an orally active third generation cephalosporin indicated for t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-01-11
Trial ID
NCT03329547
Treatments Being Tested
This study aims to evaluate the efficacy of cefixime compared to benzathine...
Status
Recruiting
Location
University of Southern California
Start Date
2021-06-20
Trial ID
NCT04958122
Treatments Being Tested
Hypotheses The antibiotic, Cefixime, for use in non-pregnant women with ear...
Status
Unknown
Location
Fortaleza University
Start Date
2019-11-22
Trial ID
NCT03752112
Treatments Being Tested
This study is a Phase I, open label, non-randomized, dose-frequency escalat...
Status
Completed
Location
Johns Hopkins Bayview Medical Center - Infectious Diseases
Start Date
2013-12
Trial ID
NCT01949363
Treatments Being Tested
Typhoid and paratyphoid (enteric) fever affects more than 11 million childr...
Status
Completed
Location
Patan Hospital
Start Date
2021-05-23
Trial ID
NCT04349826
Treatments Being Tested
The goal of the study is to evaluate the efficacy of oral cefixime as an al...
Status
Completed
Location
AHF Westside
Start Date
2018-09-03
Trial ID
NCT03660488
Treatments Being Tested
There is a strong causal association between persisting genital tract infec...
Status
Unknown
Location
Tata Memorial Hospital
Start Date
2016-07
Trial ID
NCT02830230
Treatments Being Tested
The Washington State Community Expedited Partner Therapy Trial is a stepped...
Status
Completed
Location
Washington State Department of Health
Start Date
2007-07
Trial ID
NCT01665690
Treatments Being Tested
This study evaluates the efficacy (non-inferiority) and safety of a new ant...
Status
Terminated
Location
Národní referenční laboratoř pro syfilis, Státní zdravotní ústav
Start Date
2021-07-13
Trial ID
NCT06907316
Treatments Being Tested